Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2018 / Cilt: 24 - Sayı: 2

Epigenetic Basis of Twin Discordance in Diseases: Future Benefits

Pages
108–118
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further work on epigenetic changes in diseases using incompatible monozygotic twin models, would lead to new developments in medical therapies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Monozygotic twins share the same genotype since they are derived from the same zygote.
📊
Key Findings & Data:However, monozygotic twin siblings frequently present many phenotypic differences, such as their susceptibilities to diseases.
💡
Conclusion & Impact:Further work on epigenetic changes in diseases using incompatible monozygotic twin models, would lead to new developments in medical therapies.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Monozygotic twins share the same genotype since they are derived from the same zygote. However, monozygotic twin siblings frequently present many phenotypic differences, such as their susceptibilities to diseases. These isogenic individuals are not entirely identical. They exhibit phenotypic incompatibility for many features, from birth weight to complex diseases. Recently, several studies have been published showing that phenotypic differences, especially in monozygotic twins, are being induced from prenatal period to life-long epigenetic differences. Epigenetic studies on twins have a great potential to contribute to our understanding of complex diseases, such as cancer, autoimmune disorders, psychiatric disorders and neurological diseases. Since monozygotic twins are genetic clones (genetically identical), they are considered as perfect models for studying the role of environmental factors as determinants of complex diseases and phenotypes. In this review, a number of intrauterine effects and genetic mechanisms that may affect phenotypic, genotypic, and epigenetic differences between monozygotic twins were described and effects of epigenetic mechanisms on complex diseases were mentioned. Further work on epigenetic changes in diseases using incompatible monozygotic twin models, would lead to new developments in medical therapies.

🔖

Cite This Article

DEMİR, A. B., DEMİR, N. (2018). Epigenetic Basis of Twin Discordance in Diseases: Future Benefits. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 24 - Sayı: 2, 108–118. https://ajindex.com/articles/166069

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Hall J. Twinning. Lancet 2003;362:735-43
  2. Bamford F, Brown L, Senz J Huntsman D. Mechanisms of Monozygotic twinning: A possible Role for the Cell Adhesion Molecule, E-Cadherine. Am J Med Gen 2003; 120A:59
  3. Herranz G. The timing of monozygotic twinning: a criticism of the common model. Zygote 2013:23:27-40. doi:10.1017/S0967199413000257
  4. Silva S, Martins Y, Matias A, Blickstein I. Why are monozygotic twins different? J Perinat Med 2011;39: 195- 202
  5. Zwijnenburg PJG, Meijers-Heijboer HEJ, Boomsma DI. Identical But Not the Same: The Value of Discordant Monozygotic Twins in Genetic Research. Am J Med Genet 2010; Part B 153B:1134-49
  6. Handy DE, Castro R, Loscalzo J. Epigenetic Modifications: Basic Mechanisms and Role in Cardiovascular Disease. Circulation 2011 May 17; 123(19):2145-56. doi:10.1161/CIRCULATIONAHA.110. 956839
  7. Nussbaum RL. McInnes RR. Willard HF. Epigenetic and Epigenomic Aspects of Gene Expression. Thompson & Thompson Genetics in Medicine, 8th ed. 2016;33 8. Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity 2010;105(1):4-13
  8. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54
  9. Whitelaw NC, Whitelaw E. How lifetimes shape epigenotype within and across generations. Hum Mol Genet 2006;15 Spec No 2:R131-7
  10. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007;8:253-62
  11. Szeto IM. Aziz A. Das PJ. Taha AY. Okubo N. Reza-Lopez S. Giacca A. Anderson GH. High multivitamin intake by Wistar rats during pregnancy results in increased food intake and components of the metabolic syndrome in male offspring. Am J Physiol Regul Integr Comp Physiol 2008;295:575-82
  12. Waterland RA. Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004;20:63-8
  13. Wolff GL. Kodell RL. Moore SR. Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998;Aug12(11):949- 57
  14. Lowe KE. Maiyar AC. Norman AW. Vitamin D-mediated gene expression. Crit Rev Eukaryot Gene Expr 1992;2: 65-109
  15. Takeyama K. Kojima R. Ohashi R. Sato T. Mano H. Masushige S. Kato S. Retinoic acid differentially up-regulates the gene expression of retinoic acid receptor -andisoforms in embryo and adult rats. Biochem Biophys Res Commun 1996;222:395-400
  16. Kelly KB. Kennelly JP. Ordonez M. Nelson R.